AVLNAvalyn Pharma Inc.

$27.99
$0.14
(0.49%)
Today
Closed $28.53
$0.54
(1.89%)
After Hours
Updated: 05:48 PM EDT
Reported EarningsJun 3
Mkt Cap$1.27B
Vol342,827.00

About

Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). The company was founded by Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar on May 27, 2011 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
50

Frequently Asked Questions

What is Market Cap of Avalyn Pharma Inc.?
What is the 52-week high for Avalyn Pharma Inc.?
What is the 52-week low for Avalyn Pharma Inc.?
What is Avalyn Pharma Inc. stock price today?
What was Avalyn Pharma Inc. stock price yesterday?
What is the Price-to-Book ratio of Avalyn Pharma Inc.?
What is the 50-day moving average of Avalyn Pharma Inc.?
How many employees does Avalyn Pharma Inc. have?

Advertisement|Remove ads.